Pricing Log in Create free account

HCW Biologics Inc. (HCWB) vs VivoSim Labs, Inc. (VIVS)

HCW Biologics Inc. and VivoSim Labs, Inc. are both Biotechnology companies. HCW Biologics Inc. and VivoSim Labs, Inc. are of similar size ($2.8M and $2.8M). HCW Biologics Inc. grew revenue faster over the last twelve months: 707.0% against −21.1%. HCW Biologics Inc. has the higher net margin (−329.4% vs −11,016.1%) and the lower return on invested capital (−36.2% vs 0.00%). Across the 16 metrics below, HCW Biologics Inc. leads on 9 and VivoSim Labs, Inc. on 7.

Valuation

Metric HCWB VIVS Biotechnology median
P/E n/m n/m 8.50
P/S 0.25 7.48 9.71
P/B 0.22 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.07 0.64
EV/Sales 1.17 (7.42) 9.21
Earnings yield (2,225.58%) (2,793.75%) (33.15%)
Free cash flow yield (752.91%) (143.87%) (25.50%)

Profitability

Metric HCWB VIVS Biotechnology median
Gross margin 95.91% 100.00% 65.16%
Operating margin (114.02%) (10,116.96%) 0.00%
Net margin (329.38%) (11,016.07%) 0.00%
Free cash flow margin (180.57%) (1,014.29%) 0.00%
Return on equity (600.32%) (343.10%) (56.36%)
Return on assets (79.52%) (155.93%) (48.04%)
Return on invested capital (36.15%) 0.00% 0.00%

Growth

Metric HCWB VIVS Biotechnology median
Revenue growth (TTM) 706.96% (21.13%) 6.02%
EPS growth (last fiscal year) 65.49% (214.71%) 30.26%
Revenue growth, 5-year CAGR — (43.10%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HCWB VIVS Biotechnology median
Debt to equity 0.88 0.00 0.00
Current ratio 0.06 1.70 4.72
Net debt to EBITDA (0.40) 0.45 0.96

Dividend

Metric HCWB VIVS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric HCWB VIVS Biotechnology median
Market cap 2.75m 2.84m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack